Business Wire

CO-OPTIV-SECURITY

30.5.2019 17:07:07 CEST | Business Wire | Press release

Share
Optiv Security Recognized with Second-Highest Score in Current Offering Category for Cybersecurity Incident Response Services in Independent Analyst Report

Optiv Security, a global cybersecurity integrator delivering end-to-end cybersecurity solutions, has been recognized with the second highest score in the current offering category for cybersecurity incident response services by Forrester Research. The Forrester WaveTM : Cybersecurity Incident Response Services, Q1 2019 identifies Optiv as having received the highest possible score for the criteria of incident preparation, post-incident reporting and support, and average hours per response.

The report cites that “Optiv … has an excellent current offering,” noting that “it has a well-stated engagement model, and its postmortem deliverables include remediation road maps to help clients avoid repeat occurrences, and its client references were positive across the board.” The report also states that “Optiv would be a good choice from incident preparation through remediation.”

“Today’s business decision makers are faced with driving technology, product, and business growth, while being simultaneously tasked with maintaining cyber resilient programs that are ready to react, respond to, and recover from adverse events,” said Bill Young, Optiv’s vice president and general manager of advisory threat management. “Achieving cyber resiliency requires a strategy that leverages security best practices, including proactive incident management planning, programmatic penetration testing, effective detection and response capabilities, and real-time tailored threat intelligence. By addressing enterprise cybersecurity needs from the perspective of the enemy, organizations can create more successful cyber resilient programs that are built on factual-based offensive security testing.”

Young continued, “Optiv is in a unique position in the industry to provide clients with unmatched insight, depth and breadth of services, as well as a bench that extends throughout the complete ‘plan, build, run’ cybersecurity lifecycle. We are focused on enabling our clients to move from putting out fires to preventing threat actor actions and enabling their businesses. We do this by helping organizations create, prepare, and execute incident response strategies that are honed and practiced as their organizations change, providing skilled and experienced resources to augment internal staff, and delivering supporting services, such as threat hunting and forensics capabilities that help reduce breach levels and data loss. We believe receiving the second highest score in the current offering category from Forrester validates our unique approach and the positive impact we have on our clients’ operations.”

Optiv’s enterprise incident management services help organizations reduce the likelihood of attacks or incidents, secure their environments against threats, and recover from incidents while minimizing disruption. Optiv’s full suite of EIM services can be purchased in structures aligned to the clients’ business model, thereby enabling organizations to:

  • Prepare – identify gaps in incident management strategy, hunt for and detect unknown threats within their infrastructure, document key personnel and escalation steps, validate and test response efforts for incidents and identify next steps to become more resilient.
  • Respond During and Post Incident – uncover attackers’ actions, detail the scope of a compromise, identify steps to remove active threats found in their environments, limit data loss, and improve security controls.
  • Maintain – ensure they are in a continual state of readiness for unexpected attacks or incidents with Optiv experts who are on-call and available 24x7x365. Optiv’s security and malware professionals examine clients’ systems for indicators of compromise, conduct analysis informed by a vast proprietary knowledge store of malicious code, signatures and attacks, and provide ongoing expertise.

Please visit Optiv’s website to learn more about Optiv’s incident management services .

Follow Optiv
Twitter: www.twitter.com/optiv
LinkedIn: www.linkedin.com/company/optiv-inc
Facebook: www.facebook.com/optivinc
YouTube: https://www.youtube.com/c/OptivInc
Blog: www.optiv.com/explore-optiv-insights/blog

About Optiv Security
Optiv is a global cybersecurity solutions integrator – a “one-stop” trusted partner with a singular focus on cybersecurity. Our end-to-end cybersecurity capabilities span risk management and transformation, cyber digital transformation, threat management, cyber operations, identity and data management, and integration and innovation, helping organizations realize stronger, simpler and more cost-efficient cybersecurity programs that support business requirements and outcomes. At Optiv, we are modernizing cybersecurity to enable clients to innovate their consumption models, integrate infrastructure and technology to maximize value, achieve measurable outcomes, and realize complete solutions and business alignment. For more information about Optiv, please visit us at www.optiv.com .

Contact:

Jason Cook (816) 701-3374 Jason.cook@optiv.com or Brett Ater (913) 304-7683 Brett.ater@optiv.com

Link:

ClickThru

Social Media:

https://www.facebook.com/OptivInc

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye